GNRH ANTAGONIST
Clinical trials for GNRH ANTAGONIST explained in plain language.
Never miss a new study
Get alerted when new GNRH ANTAGONIST trials appear
Sign up with your email to follow new studies for GNRH ANTAGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to starve prostate cancer by blocking testosterone
Disease control Not yet recruitingThis phase 2 trial tests a drug called teverelix DP in 40 men with advanced prostate cancer. The drug works by blocking a hormone that tells the body to make testosterone, which can fuel cancer growth. The goal is to see if a specific dosing schedule can safely lower testosterone…
Matched conditions: GNRH ANTAGONIST
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Which hormone protocol yields healthier embryos for PCOS patients?
Knowledge-focused Not yet recruitingThis study compares two common ovarian stimulation protocols—PPOS (using a progesterone-like drug) and GnRH antagonist—in women with polycystic ovary syndrome (PCOS) who are undergoing preimplantation genetic testing (PGT-A). The goal is to see which method results in more geneti…
Matched conditions: GNRH ANTAGONIST
Phase: PHASE3 • Sponsor: ShangHai Ji Ai Genetics & IVF Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC